Andrew I Rutherford

1.4k total citations · 1 hit paper
31 papers, 639 citations indexed

About

Andrew I Rutherford is a scholar working on Rheumatology, Surgery and Epidemiology. According to data from OpenAlex, Andrew I Rutherford has authored 31 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 7 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Andrew I Rutherford's work include Rheumatoid Arthritis Research and Therapies (13 papers), Autoimmune and Inflammatory Disorders Research (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Andrew I Rutherford is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (13 papers), Autoimmune and Inflammatory Disorders Research (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Andrew I Rutherford collaborates with scholars based in United Kingdom, United States and Italy. Andrew I Rutherford's co-authors include James Galloway, Sujith Subesinghe, Kimme L Hyrich, Katie Bechman, Sam Norton, Mark Russell, Fowzia Ibrahim, David Goldblatt, Andrew P. Cope and Maryam Adas and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Journal of Infection.

In The Last Decade

Andrew I Rutherford

27 papers receiving 621 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications

2023 75 citations Mark Russell, Edward Alveyn et al. Annals of the Rheumatic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew I Rutherford United Kingdom	13	303	150	135	116	115	31	639
Sujith Subesinghe United Kingdom	13	388 1.3×	157 1.0×	137 1.0×	159 1.4×	126 1.1×	26	720
René Cordtz Denmark	15	470 1.6×	200 1.3×	117 0.9×	145 1.3×	49 0.4×	48	763
Greta Carrara Italy	18	394 1.3×	130 0.9×	62 0.5×	114 1.0×	70 0.6×	58	686
Álvaro Danza Uruguay	10	553 1.8×	282 1.9×	75 0.6×	85 0.7×	67 0.6×	35	763
N. Magy‐Bertrand France	16	433 1.4×	170 1.1×	60 0.4×	247 2.1×	178 1.5×	97	970
Karin Rockwitz Germany	8	502 1.7×	189 1.3×	63 0.5×	249 2.1×	72 0.6×	12	716
R DEMAN Belgium	8	334 1.1×	158 1.1×	38 0.3×	157 1.4×	103 0.9×	14	913
J. Kh. Khizroeva Russia	15	103 0.3×	150 1.0×	79 0.6×	130 1.1×	62 0.5×	146	773
Ciriaco Aguirre Spain	10	512 1.7×	191 1.3×	51 0.4×	141 1.2×	102 0.9×	13	764
Nathalie Morel France	17	740 2.4×	233 1.6×	63 0.5×	234 2.0×	54 0.5×	44	997

Countries citing papers authored by Andrew I Rutherford

Since Specialization

Citations

This map shows the geographic impact of Andrew I Rutherford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew I Rutherford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew I Rutherford more than expected).

Fields of papers citing papers by Andrew I Rutherford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew I Rutherford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew I Rutherford. The network helps show where Andrew I Rutherford may publish in the future.

Co-authorship network of co-authors of Andrew I Rutherford

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew I Rutherford. A scholar is included among the top collaborators of Andrew I Rutherford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew I Rutherford. Andrew I Rutherford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nagra, Deepak, Katie Bechman, Mark Russell, et al.. (2024). No Waning of Pneumococcal Vaccine Responses over Time in People with Inflammatory Arthritis: Findings from a Single Centre Cohort. Vaccines. 12(1). 69–69. 1 indexed citations

Rutherford, Andrew I, et al.. (2024). OA19 Acute confusion, reduced conscious levels and stroke in systemic lupus erythematosus resulting from cerebral vasculitis. Rheumatology Advances in Practice. 8(Supplement_1).

Nagra, Deepak, Katie Bechman, Mark Russell, et al.. (2024). Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study. Lara D. Veeken. 64(5). 2479–2486. 1 indexed citations

Russell, Mark, Edward Alveyn, Maryam Adas, et al.. (2023). JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications. Annals of the Rheumatic Diseases. 82(8). 1059–1067. 75 indexed citations breakdown →

Russell, Mark, Edward Alveyn, Maryam Adas, et al.. (2023). OA08 JAK inhibitors and the risk of malignancy: a meta-analysis across licenced disease indications. Lara D. Veeken. 62(Supplement_2).

Nagra, Deepak, Katie Bechman, Maryam Adas, et al.. (2023). A Systematic Review and Meta-Analysis of Anti-Rheumatic Drugs and Pneumococcal Vaccine Immunogenicity in Inflammatory Arthritis. Vaccines. 11(11). 1680–1680. 4 indexed citations

Russell, Mark, Andrew I Rutherford, Benjamin Ellis, et al.. (2022). Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom. The Lancet Regional Health - Europe. 18. 100416–100416. 19 indexed citations

Russell, Mark, James Galloway, Colm Andrews, et al.. (2022). Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY. The Lancet Rheumatology. 4(12). e853–e863. 13 indexed citations

Russell, Mark, Edward Roddy, Andrew I Rutherford, et al.. (2022). Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England. Lara D. Veeken. 62(7). 2426–2434.

10.

Buazon, April, Jennifer Hannah, Maryam Adas, et al.. (2021). IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression. Journal of Infection. 82(5). 178–185. 35 indexed citations

11.

Bechman, Katie, Mark Yates, Deepak Nagra, et al.. (2021). Inpatient COVID-19 Mortality Has Reduced Over Time: Results from an Observational Cohort. SSRN Electronic Journal. 2 indexed citations

12.

Bechman, Katie, Benjamin D Clarke, Andrew I Rutherford, et al.. (2019). Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Lara D. Veeken. 58(10). 1767–1776. 37 indexed citations

13.

Russell, Mark, M.D. Yates, Katie Bechman, et al.. (2019). Rising Incidence of Acute Hospital Admissions due to Gout. The Journal of Rheumatology. 47(4). 619–623. 19 indexed citations

14.

Subesinghe, Sujith, Katie Bechman, Andrew I Rutherford, David Goldblatt, & James Galloway. (2018). A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis. The Journal of Rheumatology. 45(6). 733–744. 72 indexed citations

15.

Rutherford, Andrew I, et al.. (2018). Differentiating Disease Flare From Infection: A Common Problem in Rheumatology. Do 18F-FDG PET/CT Scans and Novel Biomarkers Hold The Answer?. Current Rheumatology Reports. 20(11). 70–70. 4 indexed citations

16.

Rutherford, Andrew I, Sujith Subesinghe, Kimme L Hyrich, & James Galloway. (2018). Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 77(6). 905–910. 121 indexed citations

17.

Rutherford, Andrew I, Mária Filková, Mariam Molokhia, et al.. (2017). SAT0099 Polypharmacy is associated with an increased risk of adverse outcomes in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 76. 806–806. 1 indexed citations

18.

Rutherford, Andrew I, et al.. (2016). A population study of the reported incidence of native joint septic arthritis in the United Kingdom between 1998 and 2013. Lara D. Veeken. 55(12). 2176–2180. 35 indexed citations

19.

Subesinghe, Sujith, Andrew I Rutherford, Fowzia Ibrahim, H Harris, & James Galloway. (2016). A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK. BMC Musculoskeletal Disorders. 17(1). 322–322. 43 indexed citations

20.

Rutherford, Andrew I. (1983). Osteomyelitis of the symphysis pubis.. PubMed. 96(731). 332–3. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact